Grace Therapeutics (GRCE) Earnings Date, Estimates & Call Transcripts $2.99 -0.03 (-0.99%) As of 10/10/2025 03:59 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Grace Therapeutics Earnings Summary Grace Therapeutics issued Q1 2026 earnings on August 12, 2025, reporting an EPS of -$0.21, which beat the consensus estimate of -$0.22 by $0.01. With a trailing EPS of -$0.86, Grace Therapeutics' earnings are expected to grow next year, from ($1.06) to ($0.75) per share. Upcoming Q2 Earnings DateNov. 12Before Market OpensEstimatedConsensus EPS (Aug. 12) -$0.22 Actual EPS (Aug. 12) -$0.21 Beat By $0.01 Q1 2026 Earnings ResourcesQ1 2026 Earnings Report Quarterly Report (10-Q) Press Release (8-K)GRCE Upcoming EarningsGrace Therapeutics' next earnings date is estimated for Wednesday, November 12, 2025, based on past reporting schedules. Powered by Get Grace Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Grace Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataGRCE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Grace Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.31-$0.31-$0.31Q3 20251-$0.24-$0.24-$0.24Q4 20252-$0.25-$0.20-$0.23 2025 4 -$0.80 -$0.75 -$0.78 Q2 20261-$0.12-$0.12-$0.12Q3 20261-$0.09-$0.09-$0.09Q4 20261-$0.13-$0.13-$0.13 Grace Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/12/2025(Estimated)--------8/12/2025Q1 2026-$0.22-$0.21+$0.01-$0.21--6/20/2025Q4 2025-$0.23-$0.21+$0.02$0.01--2/13/2025Q3 2025-$0.27-$0.26+$0.01-$0.36-- Grace Therapeutics Earnings - Frequently Asked Questions When is Grace Therapeutics' earnings date? Grace Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based off last year's report dates. Learn more on GRCE's earnings history. Did Grace Therapeutics beat their earnings estimates last quarter? In the previous quarter, Grace Therapeutics (NASDAQ:GRCE) reported ($0.21) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.01. Learn more on analysts' earnings estimate vs. GRCE's actual earnings. How much profit does Grace Therapeutics generate each year? Grace Therapeutics (NASDAQ:GRCE) has a recorded net income of -$9.57 million. GRCE has generated -$0.86 earnings per share over the last four quarters. What is Grace Therapeutics' EPS forecast for next year? Grace Therapeutics' earnings are expected to grow from ($1.06) per share to ($0.75) per share in the next year. More Earnings Resources from MarketBeat Related Companies Corbus Pharmaceuticals Earnings Date Actuate Therapeutics Earnings Date Compugen Earnings Date Alpha Cognition Earnings Date PepGen Earnings Date C4 Therapeutics Earnings Date Nuvectis Pharma Earnings Date Cardiff Oncology Earnings Date Theratechnologies Earnings Date Molecular Partners Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings This page (NASDAQ:GRCE) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
